DaewoongBio eyes markets of finished pharmaceuticals

Published: 2010-04-23 07:00:00

Updated: 2010-04-23 07:00:00

DaewoongBio, a local maker for pharmaceutical raw materials, seeks to take the lead in the domestic and overseas market by launching a new drug business unit, a company official said on April 19.

The business unit will be partnering with Daewoong Pharm, the holding firm, to undertake the inten...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK